Intervention not reported
Adverse events · patients with LADA
1 finding from 1 review
Intervention not reported
Health‐related quality of life · patients with LADA
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Death from any cause · patients with LADA
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Health service utilisation and costs · patients with LADA
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
HbA1c at study endpoint · patients with LADA
1 finding from 1 review
Mortality ‐ not reported · patients with type 2 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life and treatment satisfaction ‐ not reported · patients with type 2 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
HbA1c (glycated haemoglobin), change · patients with type 2 diabetes mellitus
1 finding from 1 review
Percentage of participants having at least one severe hypoglycaemic event · patients with type 2 diabetes mellitus
Insulin detemir (intervention) showed no clear difference in percentage of participants having at least one severe hypoglycaemic… compared with insulin glargin (control) (low certainty).
1 finding from 1 review
Percentage of participants having at least one hypoglycaemic event · patients with type 2 diabetes mellitus
Insulin detemir (intervention) showed no clear difference in percentage of participants having at least one hypoglycaemic event compared with insulin glargin (control) (low certainty).
1 finding from 1 review
Weight gain · patients with type 2 diabetes mellitus
1 finding from 1 review
Injection‐site reaction Rates of patients · patients with type 2 diabetes mellitus
Insulin detemir (intervention) may leads to higher percentage of participants having at least one injection site reaction compared with insulin glargin (control) (low certainty).
1 finding from 1 review
Cardiovascular events ‐ not reported · patients with hypercholesterolemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life ‐ not reported · patients with hypercholesterolemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · patients with hypercholesterolemia
1 finding from 1 review
Costs · patients with hypercholesterolemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
LDL‐cholesterol · patients with hypercholesterolemia
1 finding from 1 review
HDL‐cholesterol · patients with hypercholesterolemia
1 finding from 1 review
Death from any cause ‐ not reported · patients with hypercholesterolemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life ‐ not reported · patients with hypercholesterolemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found